GT Biopharma moves to Withdraw its Form S-1 Registration Statement
2025-02-25 08:28:13 ET
DENVER, Colo., Feb 25, 2025 ( 247marketnews.com )- GT Biopharma (NASDAQ: GTBP ) moved to withdraw its Form S-1 Registration Statement (File No. 333-284032), originally filed with the SEC on December 23, 2024. This filing, which had not yet gone effective and involved no securities sales, was poised to raise capital through a public offering. The strategic retreat helps avoid dilution, preserves flexibility, and potentially boosting long-term valuation, GT Biopharma’s move could be a win for its investors.
The immediate boon for GTBP shareholders is the sidestepping of dilution. The S-1, amended on February 7, proposed issuing up to 3,361,344 shares and warrants at $2.38—a 150% increase over the 2.23 million shares outstanding (as of January 9, 2025).
By withdrawing, GTBP preserves its tight float and helps shield shareholders from the value erosion.
The post GT Biopharma moves to Withdraw its Form S-1 Registration Statement appeared first on 24/7 MarketNews .
For further details see:
GT Biopharma moves to Withdraw its Form S-1 Registration Statement
NASDAQ: GTBP
GTBP Trading
-7.18% G/L:
$0.4084 Last:
1,935,580 Volume:
$0.4508 Open:
